Nirmatrelvir-ritonavir (Paxlovid) Access, Use, and Eligibility Among Adults with COVID-19 in Los Angeles County: The LA Pandemic Surveillance Cohort Study

被引:0
|
作者
Lee, Ryan [1 ]
Sood, Neeraj [2 ]
Lam, Chun Nok [3 ]
Unger, Jennifer B. [1 ]
Herzig, Shirin Emma [1 ]
Hu, Howard [1 ]
机构
[1] Univ Southern Calif, Keck Sch Med, Dept Populat & Publ Hlth Sci, Los Angeles, CA 90007 USA
[2] Univ Southern Calif, Sol Price Sch Publ Policy, Los Angeles, CA USA
[3] Univ Southern Calif, Keck Sch Med, Dept Emergency Med, Los Angeles, CA USA
关键词
D O I
10.1007/s11606-023-08591-9
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:79 / 86
页数:8
相关论文
共 50 条
  • [1] Nirmatrelvir-ritonavir (Paxlovid) Access, Use, and Eligibility Among Adults with COVID-19 in Los Angeles County: The LA Pandemic Surveillance Cohort Study
    Ryan Lee
    Neeraj Sood
    Chun Nok Lam
    Jennifer B. Unger
    Shirin Emma Herzig
    Howard Hu
    Journal of General Internal Medicine, 2024, 39 : 1081 - 1083
  • [2] Effectiveness of Azvudine and Nirmatrelvir-ritonavir in Kidney Transplant Recipients With COVID-19: A Retrospective Cohort Study
    Liu, Y.
    Zhang, H.
    Liu, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [3] Real-world effectiveness and safety of oral azvudine versus nirmatrelvir-ritonavir (Paxlovid) in hospitalized patients with COVID-19: a multicenter, retrospective, cohort study
    Wang, Haiyu
    Cui, Guangying
    Cheng, Ming
    Aji, Tuerganaili
    Li, Guotao
    Hu, Xinjun
    Li, Guangming
    Zhang, Shixi
    Zhang, Yanyang
    Diao, Linqi
    Li, Pan
    Wang, Ling
    Yuan, Yiqiang
    Qian, Guowu
    Zhang, Ruiqing
    Jin, Xiaoli
    Wang, Juan
    Luo, Hong
    Zhang, Donghua
    Wang, Mingming
    Li, Silin
    Song, Zhan
    Yang, Mengzhao
    Su, Guanyue
    Sun, Ranran
    Chang, Junbiao
    Yu, Zujiang
    Ren, Zhigang
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2025, 10 (01)
  • [4] Clinical characteristics of COVID-19 rebound after nirmatrelvir-ritonavir or molnupiravir therapy: A prospective cohort study
    Han, Jaijun
    Bae, Seongman
    Jung, Jiwon
    Kim, Min Jae
    Chong, Yong Pil
    Lee, Sang-Oh
    Choi, Sang-Ho
    Kim, Yang Soo
    Chang, Euijin
    Kim, Sung-Han
    MEDICINE, 2023, 102 (39) : E35094
  • [5] Real-world effectiveness and safety of nirmatrelvir-ritonavir (Paxlovid)-treated for COVID-19 patients with onset of more than 5 days: a retrospective cohort study
    Qiu, Ye
    Wen, Hao
    Wang, Haoru
    Sun, Wenjun
    Li, Guangchao
    Li, Shaoqiang
    Wang, Yan
    Zhai, Jingnan
    Zhan, Yangqing
    Su, Yutian
    Long, Zhiwei
    Li, Zhengtu
    Ye, Feng
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [6] Self-reported dietary changes among Los Angeles County adults during the COVID-19 pandemic
    Miller, Sydney
    de Bruin, Wandi Bruine
    Livings, Michelle
    Wilson, John
    Weber, Kate
    Frazzini, Alison
    Babboni, Marianna
    de la Haye, Kayla
    APPETITE, 2021, 166
  • [7] The Differential Experience of COVID-19 on Asian American Subgroups: The Los Angeles Pandemic Surveillance Cohort Study
    Lam, Chun Nok
    Tam, Benjamin
    Kawaguchi, Eric S.
    Unger, Jennifer B.
    Hur, Kevin
    JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES, 2023, 11 (5) : 2806 - 2815
  • [8] Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe COVID-19: An Analysis of the National Covid Cohort Collaborative (N3C)
    Xiao, Xuya
    Alexander, G. Caleb
    Mehta, Hemalkumar B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 198 - 199
  • [9] Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe COVID-19: An Analysis of the National COVID Cohort Collaborative (N3C)
    Xiao, Xuya
    Alexander, G. Caleb
    Mehta, Hemalkumar B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (08)
  • [10] A retrospective cohort study of prescribing outcomes in outpatients treated with nirmatrelvir-Ritonavir for COVID-19 in an interdisciplinary community clinic
    Leung, Valerie
    Gill, Suzanne
    Llanes, Andrea
    Khawaja, Armughan
    Stagg, Amanda
    Mccready, Janine
    Jacubovich, Mariana
    Ho, Grace
    Powis, Jeff
    Kandel, Christopher
    PLOS ONE, 2023, 18 (10):